You are here: Industry Insights > COVID-19 Vaccine

News List

FDA grants Emergency Use Authorization for Pfizer’s COVID-19 vaccine BNT162b2 europeanpharmaceuticalreview
December 15, 2020
The US has approved emergency use of Pfizer and BioNTech’s COVID-19 vaccine, BNT162b2, in people 16 years of age and older.
Bahrain approves Sinopharm’s Covid-19 vaccine registration pharmaceutical-technology
December 15, 2020
The Bahrain National Health Regulatory Authority (NHRA) has approved the registration of the Covid-19 vaccine by Chinese company Sinopharm.
US begins transportation of COVID-19 vaccine to distribution points around the country expresspharma
December 15, 2020
Cargo planes and trucks with the first US shipments of coronavirus vaccine fanned out from FedEx and UPS hubs in Tennessee and Kentucky on Sunday en route to distribution points around the country, launching an immunisation project of unprecedented ...
Moderna signs supply agreement with Singapore for COVID-19 vaccine expresspharma
December 15, 2020
Moderna recently announced data showing that mRNA-1273 remains stable at 2° to 8°C (36° to 46°F), the temperature of a standard home or medical refrigerator, for 30 days.
FDA takes key action in fight against COVID-19 by issuing Emergency Use Authorization for first COVID-19 vaccine worldpharmanews
December 14, 2020
The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 ...
Tampa General Hospital is Preparing to Accept the First Shipment of COVID-19 Vaccine prnewswire
December 14, 2020
Tampa General Hospital is expecting to receive doses of the Pfizer two-dose COVID-19 vaccine sometime this week or next as part of the state's pilot program to fight the global coronavirus.
Sanofi and GSK postpone Covid-19 vaccine trial to optimise candidate pharmaceutical-technology
December 14, 2020
Sanofi and GlaxoSmithKline (GSK) have decided to delay their Covid-19 vaccine programme because their adjuvanted recombinant protein vaccine failed to produce a sufficient immune response in older adults enrolled in a US Phase I/II trial.
ImmunityBio COVID-19 vaccine candidate shows protection of airways in non-human primates expresspharma
December 14, 2020
The hAd5-COVID-19 candidate is designed to address a potential problem that may emerge when first-generation adenoviral platforms are used as vaccine vectors: vaccine inactivation due to pre-existing immunity to the vector itself.
CDSCO to identify and set up two additional facilities for testing COVID-19 vaccines expresspharma
December 14, 2020
The CDSCO has identified the challenges associated with COVID-19 vaccines are taking steps to mitigate them, informs Dr Eswara Reddy.
US FDA gives EUA for Pfizer/BioNTech COVID-19 vaccine expresspharma
December 14, 2020
The US Food and Drug Administration (USFDA) granted an emergency use authorisation for Pfizer and BioNTech’s COVID-19 vaccine which was shown to be 95 per cent effective in preventing the disease in a late-stage trial.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page